WW International, Inc.'s SEC filings document the regulatory record for Weight Watchers' subscription-based weight-management and clinical businesses. Recent Forms 8-K furnish quarterly results, shareholder letters, Regulation FD disclosures about term-loan prepayment actions, and material governance events involving directors, board committees and interim executive officers.
The company's proxy materials cover annual-meeting voting matters, director elections, board independence, committee service and non-employee director compensation. Its filings also identify WW common stock, no par value, registered on the Nasdaq Stock Market and provide formal disclosure of capital-structure, compensation and corporate-governance matters.
Sjoqvist Nikolaj H reported acquisition or exercise transactions in this Form 4 filing.
WW INTERNATIONAL, INC. director Nikolaj H Sjoqvist received a grant of 8,132 Restricted Stock Units, each representing a contingent right to receive one share of common stock. The award was granted on August 10, 2026 and will vest on August 10, 2027, or earlier on the business day immediately preceding the next annual shareholders meeting. Following this grant, he directly holds 8,132 RSUs.
DAVIS EUGENE I reported acquisition or exercise transactions in this Form 4 filing.
WW INTERNATIONAL, INC. director Eugene I. Davis received a grant of 8,132 Restricted Stock Units on August 10, 2026. Each unit represents a contingent right to receive one share of common stock. The award will vest on August 10, 2027 or the business day immediately before the next annual shareholders’ meeting, whichever occurs first. Following this grant, Davis holds 8,132 RSUs directly.
Gavales Lisa A reported acquisition or exercise transactions in this Form 4 filing.
WW INTERNATIONAL, INC. director Lisa A. Gavales received a grant of 8,132 Restricted Stock Units on August 10, 2026. Each unit represents a contingent right to receive one share of common stock. The award will vest on August 10, 2027, or the business day immediately preceding the next annual shareholders meeting, whichever is earlier, resulting in 8,132 common shares if fully vested.
Hawks Carney reported acquisition or exercise transactions in this Form 4 filing.
WW International, Inc. reported that director Hawks Carney received a grant of 8,132 Restricted Stock Units on August 10, 2026. Each unit represents a contingent right to receive one share of common stock and will vest on August 10, 2027 or, if earlier, the business day immediately preceding the next annual shareholders’ meeting. Following this grant, Carney directly holds 8,132 RSUs tied to common stock.
Thiltgen Heather reported acquisition or exercise transactions in this Form 4 filing.
WW INTERNATIONAL, INC. director Heather Thiltgen received a grant of 8,132 Restricted Stock Units on August 10, 2026. Each unit represents a contingent right to receive one share of common stock. The award will vest on August 10, 2027, or earlier on the business day immediately preceding the next annual shareholders’ meeting. Following this grant, Thiltgen holds 8,132 RSUs directly.
WW International reported Q2 2026 net revenue of $162.3 million and net income of $14.1 million, or $1.41 per diluted share, driven by Behavioral subscription revenue of $121.5 million and Clinical subscription revenue of $39.9 million, with a gross margin of 70.3%.
For the first six months of 2026, revenue was $330.6 million and the company recorded a net loss of $37.9 million, with diluted loss per share of $3.79. Cash and restricted cash totaled $107.3 million at June 30, 2026, against approximately $424 million of long-term debt under a term loan maturing in 2030.
WW, which emerged from Chapter 11 in June 2025 and now operates with a $465.0 million senior secured term loan structure, continues to report as a single segment across Behavioral and Clinical offerings. Management states it does not foresee needing additional liquidity in the next 12 months but notes that the Behavioral reporting unit and trade name intangible are both close to potential impairment thresholds.
WW International reported Q2 2026 revenue of $162.3 million, compared with $189 million in combined Q2 2025, as Behavioral subscription revenue declined while the higher-priced Clinical offering expanded. Gross margin was 70.3%, Adjusted gross margin 73.6%, and net income was $14.1 million, with Adjusted EBITDA of $39.8 million (24.5% margin).
Total End of Period subscribers were 2.489 million, down 21.4% year-over-year, driven by a 24.6% decline in Behavioral subscribers, while End of Period Clinical subscribers grew 55.7% to 197 thousand. Core+, the higher-value Behavioral tier, reached 541 thousand subscribers and delivered a third consecutive quarter of sequential growth. Q2 marketing expense was $47.9 million, or 29.5% of revenue, after elevated peak-season spending in Q1. The company used $36.8 million of cash to reduce term-loan principal by $41.4 million, cutting annualized interest expense by about $4 million and ending the quarter with $101.5 million in cash. WW reaffirmed full-year 2026 guidance for $620–$635 million of revenue and $105–$115 million of Adjusted EBITDA.
WW International, Inc. ownership disclosure: a Schedule 13G/A amendment states that Integrated Core Strategies (US) LLC reports 559,833 shares ( 5.6%) and Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report 600,044 shares ( 6.0%) as disclosed on the cover pages. The filing is accompanied by a Joint Filing Agreement dated June 16, 2026.
Gavales Lisa A reported acquisition or exercise transactions in this Form 4 filing.
WW International director Lisa A. Gavales received a grant of 813 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of WW International common stock at no purchase price.
The RSUs were granted on June 15, 2026 and will vest on June 15, 2027, or earlier on the business day immediately before the company’s next annual shareholder meeting. Following this grant, Gavales holds 813 RSUs directly, reflecting a routine equity compensation award rather than an open-market trade.
DAVIS EUGENE I reported acquisition or exercise transactions in this Form 4 filing.
WW International, Inc. director Eugene I. Davis reported a grant of 1,997 Restricted Stock Units on June 15, 2026. Each unit represents a right to receive one share of common stock at no purchase price.
The RSUs will vest on June 15, 2027, or earlier on the business day immediately before the company’s next annual shareholder meeting. Following this award, Davis holds 1,997 RSUs directly.